MoneyJuly 16, 2026via AI News
Neko Health raises $700 million to expand AI body scans in the US
Why it matters
A major Series C signals investor conviction in AI-driven healthcare diagnostics as a defensible, high-margin business model. This isn't a model release or feature drop—it's capital flowing toward applied AI in regulated verticals.
Key signals
- $700M Series C funding round
- Led by Lightspeed Venture Partners, co-led by O.G. Venture Partners
- US expansion starting with New York clinic
- Service combines medical imaging, blood tests, proprietary sensors, clinician review
- Preventive screening use case
The hook
$700M. Neko Health just bet big on AI-powered preventive screening—and it's coming to your neighborhood.
Neko Health has raised $700 million to expand its AI body scans in the United States, starting with a clinic in New York. The company’s preventive screening service combines medical imaging, blood tests, proprietary sensors, and clinician review. The Series C round was led by Lightspeed Venture Part…